TABLE 3

Chemosensitivities of CEM, CEM-ARAC/hENT2, CEM-ARAC/hCNT1, CEM-ARAC/hCNT2, and CEM-ARAC cells to BR and TR Actively proliferating cells were exposed to graded concentrations of BR or TR in 96-well plates for 4 and 48 h as described under Materials and Methods. In protection experiments, CEM cells were treated with 1 μM NBMPR 1 h before the addition of BR or TR in the presence of 1 μM NBMPR. IC50 values were obtained from the MTS-cytotoxicity relationships and are means of at least two experiments, each conducted with six replicates. Mean ± S.E. values were determined using GraphPad Prism software version 3.0.

IC50
BR TR
4 h 48 h 4 h 48 h
μM
CEMa 11 ± 2.9 1.7 ± 0.28 >500 78 ± 2.5
   + 1 μM NBMPR 46 ± 5.7 6.0 ± 0.75 >500 130 ± 6.2
CEM-ARAC/hENT2 9 ± 3.5 2.5 ± 0.31 >500 110 ± 5.1
CEM-ARAC/hCNT1 42 ± 9.2 2.8 ± 0.18 >500 130 ± 21
CEM-ARAC/hCNT2 108 ± 15 6.6 ± 0.4 >500 106 ± 15
CEM-ARACb 107 ± 17 6.5 ± 0.42 >500 110 ± 5
  • a CEM has endogenous hENT1 activity

  • b CEM-ARAC is nucleoside transport-defective